Skip to content

PolitiKit

Gaby Bourbara's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

Gaby Bourbara

President

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
63
Since Nov 2021
91
Active registrations
1

Reported meetings

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Engagement with the Government regarding the Strategic Innovation Fund (SIF) and investment in Canada.

    Official report

    • Samir Khan · Associate Executive Director, Health Canada (HC)
    Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance. Read more

    Official report

    • Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Engagement with the Government regarding the Strategic Innovation Fund (SIF) and investment in Canada. Read more

    Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry

    Official report

    • Michael Mosier · Senior Director, Finance Canada (FIN)
    Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry Read more

    Official report

    • Jay Allen · Minister (Economic), Global Affairs Canada (GAC)
    • Kaitlyn Pritchard · Trade Program Manager, Innovation & Industrial Policy, Global Affairs Canada (GAC)
    Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry Read more

    Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance.

    Official report

    • Galen Richardson · Senior Advisor, Stakeholder Relations, Global Affairs Canada (GAC)
    • Miro Froehlich · Director of Policy, Global Affairs Canada (GAC)
    • Nasser Haidar · Senior Policy Advisor, Global Affairs Canada (GAC)
    Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry Read more

    Official report

    • Alexandre Boulé · Senior Advisor, Prime Minister's Office (PMO)
    • Shaili Patel · Deputy Director of Policy, Prime Minister's Office (PMO)
    Engagement with the Government regarding the Strategic Innovation Fund (SIF) and investment in Canada. Read more

    Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry

    Official report

    • Mélanie Joly · Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry Read more

    Engagement with the Government regarding the Strategic Innovation Fund (SIF) and investment in Canada.

    Official report

    • Sandenga Yeba · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
    • Shahad Khalladi · Senior Policy Advisor, Health Canada (HC)
    Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance. Read more

    Engagement with the Government regarding the Strategic Innovation Fund (SIF) and investment in Canada.

    Official report

    • Kasondra White · Director General, Innovation, Science and Economic Development Canada (ISED)
    • Heather Earle · Deputy Director, Innovation, Science and Economic Development Canada (ISED)
    Public health and prevention programs including the Public Health Agency of Canada and efforts to support the development and procurement of innovative vaccines and therapies to address major public health issues such as COVID-19 and RSV. Read more

    Official report

    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Director for Innovation, Science and Economic Development, Innovation, Science and Economic Development Canada (ISED)
    Engagement with the Government regarding the Strategic Innovation Fund (SIF) and investment in Canada.

    Official report

    • Cynthia Colapinto · Director, Policy and Data Division, Health Canada (HC)
    • Ursula Polack · Senior Advisor, Health Canada (HC)
    Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance. Read more

    Official report

    • Samir Khan · Associate Executive Director, Health Canada (HC)
    Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance. Read more

    Official report

    • Patrick Halley · Assistant Deputy Minister, Finance Canada (FIN)
    • Gabriel Williams · Analyst, Finance Canada (FIN)
    Scientific Research and Experimental Development (SR&ED) Tax Incentive Program regarding eligible expenditures. Discussions on policies such as "patent box" and Investment Tax Credits. Read more

    Official report

    • Marc-Andre Blais · Senior Investment Manager, Innovation, Science and Economic Development Canada (ISED)
    • Robin Kirkpatrick · Senior Investment Analyst, Innovation, Science and Economic Development Canada (ISED)
    Updates to, and implementation of, the Biomanufacturing and Life Sciences Strategy to support investments in Canada.

    Official report

    • Samuel Millar · Assistant Deputy Minister, Finance Canada (FIN)
    • Mallika Nanduri Bhatt · Associate Assistant Deputy Minister, Finance Canada (FIN)
    Updates to, and implementation of, the Biomanufacturing and Life Sciences Strategy to support investments in Canada.

    Official report

    • Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Director for Innovation, Science and Economic Development, Innovation, Science and Economic Development Canada (ISED)
    Updates to, and implementation of, the Biomanufacturing and Life Sciences Strategy to support investments in Canada.

    Official report

    • François-Philippe Champagne · Minister, Innovation, Science and Economic Development Canada (ISED)
    • Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Laurel Chester · Sr Advisor, Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Updates to, and implementation of, the Biomanufacturing and Life Sciences Strategy to support investments in Canada.

    Official report

    • Carlos Pena · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)

    HealthIndustry

    Official report

    • Valerie Bradford · Member of Parliament, House of Commons

    HealthIndustry

    Official report

  • HealthIndustry

    Official report

  • HealthIndustry

    Official report

  • HealthIndustryResearch and Development

    Official report

    • Pierre Paul-Hus · Member of Parlliament
    • Aymeline Slama · Constituency Assistant, House of Commons

    IndustryResearch and Development

    Official report

    • Eshan Naik · Director of Policy, Health Canada (HC)

    Economic DevelopmentResearch and Development

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.